Global X Genomics & Biotechnology ETF
$GNOM · Global X · tracks Solactive Genomics Index · since 2019
Dividend yield
0.00%
Expense ratio
0.50%
Assets
$0.2B
About GNOM
GNOM invests in companies advancing genomics, gene editing, molecular diagnostics, and bioinformatics — including CRISPR pioneers, sequencing platforms, and synthetic biology firms. The fund offers concentrated exposure to next-generation healthcare innovation but is highly volatile given the early-stage nature of many constituents.
Top holdings
Sector exposure
- Biotechnology64.2%
- Healthcare Equipment22.4%
- Life Sciences Tools11.6%
- Other1.8%
How StockWorthy analyses GNOM
ETFs hold companies rather than generating cash flow themselves, so GNOM is assessed on cost, income and the valuation of what it owns: the expense ratio, the current yield against its own long-run average, and a holdings-weighted P/E and growth rate built from the underlying positions. Figures are educational and not investment advice.
Sign in to see live pricing, yield history and the full holdings breakdown, or browse all ETFs.